Redmile Group
Investor profile | Builders Republic
About
Redmile Group is a global healthcare investment firm focused on life sciences, investing across both private (venture/growth) and public markets in biotech, medtech, and health technology, with a crossover approach and long‑term, research‑driven strategy.
Key facts
- Type
- IM / Cross-over Fund
- Stages
- Series A,Series B,Growth,Pre-IPO,Listed
- Sectors
- Healthcare,Biotech,Medtech,Diagnostics,Digital health
- Headquarters
- US
- Offices
- San Francisco,New York
- Geographic focus
- France,Europe,USA
- Lead / Follow
- Can lead and follow
- Founded
- 2007
Notable investments in France
One Biosciences, Home Biosciences, Mnemo Therapeutics
Key differentiators
Sector Specialist,Transatlantic footprint